Table 2.
Patients’ demographics and tumor characteristics
| Characteristics | n = 39 |
|---|---|
| Patients’ demographics | |
| Age (years) | 73.3 ± 7.1 (59–84) |
| Gender (Male:Female) | 18 (46):21 (54) |
| Body mass index (kg/m2) | 20.7 ± 3.5 (14.9–31.5) |
| CEA (ng/mL) | 4.2 ± 3.7 (0.9–20.2) |
| CA19-9 (U/mL) | 285.7 ± 404.7 (0.1–1818.8) |
| Tumor characteristics | |
| Location (head/body/tail) | 21/11/7 |
| Tumor size (mm) | 18.7 ± 5.3 (9.2–30.6) |
| pT stage (0/1a/1b/1c/2/3/4) | 1/0/0/9/26/3/0 |
| pN stage (0/1/2) | 15/13/11 |
| TNM stage (1A/1B/2A/2B/3/4) | 6/9/0/13/11/0 |
| Tumor differentiation (wel/mod/por) | 8/29/2 |
| R classification (0/1) | 33/6 |
| Massive intratumoral necrosis (−/ +) | 28/11 |
Data are means ± 1 standard deviation with ranges in parentheses
CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9